Archive for the ‘Mobile Devices’ Category
Apple recently made its “iWork for iCloud” app suite available to all users at no cost, even those without an Apple device. iWork for iCloud is web-only access and features web versions of Pages, Numbers, and Keynote for creating documents, spreadsheets and presentations. To access this trio of productivity apps, you will need to create an Apple ID on iCloud.com, if you don’t already have one. Sign-up is free and includes 1GB of free storage for saving documents.
To create an Apple ID:
- Go to iCloud.com.
- Click Create Apple ID.
- Fill out the required account information including your email address, a strong password, and security questions.
- Verify your email address by entering the 6-digit code that Apple sends you.
- Accept the iCloud Terms of Service.
iCloud.com supports recent versions of Safari, Firefox, Chrome, and Internet Explorer. Learn more about the system requirements for iCloud.
The National Library of Medicine (NLM) has issued a call for participation in a Pill Image Recognition (PIR) Request for Information (RFI). Unidentified and misidentified prescription pills present challenges for individuals and professionals. Unidentified pills can be found by family members, health professionals, educators, and law enforcement. The nine out of 10 US citizens over age 65 who take more than one prescription pill can be prone to misidentifying those pills.
This PIR RFI is a pilot for a forthcoming PIR Challenge whose goal is to develop smart phone apps that individuals can use to take pictures of prescription pills and then search for and retrieve pill images and associated data of likely matches in an NLM database. NLM anticipates that respondents will include professionals and students, individually or in teams, in computer vision and computer graphics working on content-based image retrieval. Instructions for responding to the RFI are available on the PIR website.
The deadline for submissions to this RFI is Monday, April 27, 2015.
Are you curious about the use of smart phones, tablets, or other mobile data resources to collect data for your assessment project, but are seeking more information on how to determine if this is the right approach for your project or program and how to process the data you collect using this method? Then check out Mobile Data Solutions, which was created as part of the Mobile Solutions Technical Assistance and Research (mSTAR) project, with expertise provided by U.S. Agency for International Development’s (USAID) Digital Development Lab and designed by TechChange.
The primary goal of this freely available and accessible online course (free registration is required) is to learn more about mobile tools, processes, and strategies for data collection in order to use mobile devices (referred to as mobile data solutions) to their full potential. The course will take about two hours to complete and can be done at your own pace over time. Progress in the course is saved so you’ll be taken to the point where you stopped to continue learning the next time you access it.
The learning objectives of the course are:
- Describe examples of mobile data solutions from collection through visualization
- Articulate the benefit of using these solutions
- Analyze the challenges and limitations associated with mobile data solutions
- Assess whether or not particular mobile data solutions are appropriate for a project, program or problem
- Outline how to design a project or activity to include mobile data solutions
- Explain the steps involved in implementing mobile data solutions
- Summarize how to analyze, visualize, and share mobile data
AIDSinfo has announced the release of the AIDSinfo HIV/AIDS Drug Database app. Using data from the AIDSinfo Drug Database, the drug app provides information on more than 100 HIV-related approved and investigational drugs. The information, offered in English and Spanish, is tailored to meet the needs of both health care providers and consumers. The app is designed to automatically refresh when the user is connected to a wireless or cellular data network. The auto update feature eliminates the need to manually update the app to view the most current drug information. In addition, the app works offline, ensuring that health care providers and consumers can access vital drug information anywhere, even in health care facilities that may not have an Internet connection.
Health care providers surveyed on the AIDSinfo website indicated that access to Food and Drug Administration (FDA) labels for HIV-related drugs would be a useful feature of a drug app. Thus FDA drug labels pulled from DailyMed are integrated into the app in an easy-to-navigate format. This feature, coupled with the auto update feature, makes it easy for health care providers to quickly find the latest drug information when seeing patients. In addition, information from the FDA labels is condensed in easy-to-understand summaries in English and Spanish for consumers. The app also includes information on HIV-related investigational drugs for both health care providers and consumers.
Available for both iOS and Android devices, users can personalize the free AIDSinfo Drug App to suit their needs:
- Receive notifications when content is updated.
- Bookmark frequently referenced drugs for easy access at any time.
- Add personal notes to any drug.
- Select from a menu of alarms to set pill reminders for any drug.
AIDSinfo also has the AIDSinfo Glossary of HIV/AIDS-Related Terms app, available for both iOS and Android devices, which includes English and Spanish definitions of more than 700 HIV/AIDS-related terms.
The National Library of Medicine has just announced the release of new versions of the MedlinePlus Mobile sites in English and Spanish. Like the original versions of the mobile sites, the redesigned sites are optimized for mobile phones and tablets. Unlike the original mobile sites that contained only a subset of the information available on MedlinePlus, the new sites have all of the content found on MedlinePlus and MedlinePlus en español! They also have an improved design for easier use on mobile devices. Illustrations of the new sites are available in the NLM Technical Bulletin.
The key features of the redesigned mobile sites are:
- Access to all the content available on MedlinePlus and MedlinePlus en español
- Improved navigation using “Menu” and “Search” options to access search and major areas of the sites
- Enhanced page navigation with the ability to open and close sections within pages
- Updated look and feel with a refreshed design
This new version of MedlinePlus Mobile is the first step in redesigning MedlinePlus and MedlinePlus en español to behave responsively. Responsively designed Web sites automatically change their layouts to fit the screen of the device on which they are viewed, whether that is a desktop monitor or a mobile touchscreen. In 2015, the MedlinePlus team will release a fully responsive version of MedlinePlus to provide a consistent user experience from the desktop, tablet, or phone. This will obviate the need for a separate mobile site. Users will then have one destination for MedlinePlus when using any device. Until then, try out this first offering of MedlinePlus’s responsive design on your smartphone! Feel free to send feedback and comments about the new site via the “Contact Us” link that appears on every page.
The National Library of Medicine (NLM) Drug Information Portal is a free web resource that provides an informative, user–friendly gateway to current drug information for over 53,000 substances. The Portal links to sources from the NLM, the National Institutes of Health (NIH), and other government agencies such as the U.S. FDA. Current information regarding consumer health, clinical trials, AIDS–related drug information, MeSH pharmacological actions, PubMed biomedical literature, and physical properties and structure is easily retrieved by searching a drug name. A varied selection of focused topics in medicine and drug–related information is also available from displayed subject headings.
The Drug Portal retrieves by the generic or trade name of a drug or its category of usage. Records provide a description of how the drug is used, its chemical structure and nomenclature, and include up to 20 Resource Locators which link to more information in other selected resources. Recent additions to these Locators include clinical experience with drugs in PubMed Health, substances reviewed in NLM’s LiverTox, information from the Dietary Supplement Label Database, and drug images in the Pillbox database. Data in the Drug Information Portal is updated daily, and is also available on mobile devices. More information is available from the Drug Information Portal Fact Sheet.
ChemIDplus is a dictionary of over 400,000 chemicals (names, synonyms, and structures). It includes links to NLM and other databases and resources, including ones to over 100 federal, state and international agencies. ChemIDplus Lite is designed for simple searching on name or registry number. ChemIDplus Advanced helps users draw their own structures and perform similarity and substructure searches. ChemIDplus records are updated daily. The following new features are now available:
- A new “3D” button on search results pages provides calculated three dimensional structure models for over 300,000 chemicals and 645,000 variations. Users can adjust the rotation speed, the image type (ball and stick, space fill, wireframe), and 3D angle of viewing; dragging the image changes its orientation. Right clicking on the structure box provides other control options such as color, style, measurements, and computation. The open source JSMol program is used for viewing these models. Another feature offers 3D when viewed with Red/Cyan, Red/Green or Red/Blue glasses, allowing for unique visualization of a molecule with depth perception.
- ChemIDplus is now IPhone IOS and Android OS friendly. Buttons collapse to neatly fit the phone screen, and the structures can be displayed.
The Centers for Disease Control and Prevention (CDC) has announced the release of a new CDC Blast Injury mobile application, which may be downloaded for free from the iTunes store. The program is designed to assist in the response and clinical management of injuries resulting from terrorist bombings and other mass casualty explosive events. The application provides clear, concise, up-to-date medical and healthcare systems information to assist healthcare providers and public health professionals in the preparation, response, and management of injuries resulting from terrorist bombing events. CDC is hosting a Google+ Hangout on Monday, June 30, at 8:30 AM PDT to discuss this new tool.
AIDSinfo, a service of the US Department of Health and Human Services (HHS), recently updated its AIDSinfo (English) and infoSIDA (Spanish) Web sites. They are now automatically optimized for display across all devices, including desktop computers, tablets, and smartphones. Visitors to the AIDSinfo and infoSIDA Web sites will now be able to access all of the content on any device they are using. AIDSinfo offers access to the latest, federally approved HIV/AIDS medical practice guidelines, HIV treatment and prevention clinical trials, and other research information for health care providers, researchers, people affected by HIV/AIDS, and the general public.
NLM decided to create a responsive design Web site, a site that automatically adjusts to any device, because of a shift in the ways that people are accessing the Internet. Between 2010 and 2014, mobile traffic to the AIDSinfo Web site increased tenfold, and almost 90% of health care providers surveyed on the AIDSinfo Web site have Internet access at the point of care, and of those, more than two-thirds use a mobile device when seeing patients. With this redesign, health care providers, researchers, people with HIV/AIDS, their family and friends, and anyone who visits the Web site will now be able to access the HIV/AIDS medical practice guidelines, drug database, fact sheets, clinical trials search, HIV/AIDS glossary, and all of the other features in an easy-to-navigate format no matter what device they are using.
If you have saved the mobile site URLs (http://m.aidsinfo.nih.gov/ and http://m.infosida.nih.gov/) as a Bookmark or Favorite on your tablet or smartphone, you will be automatically redirected to the responsive design Web site. Please send your questions or feedback about the responsive design Web site to: ContactUs@aidsinfo.nih.gov.
NLM has just released the latest version of WISER for the Android (version 3.1) to the Google Play store. This release brings the Help Identify and Protective Distance Mapping functions to Android devices (it is already on the Windows, iOS, BlackBerry and WebWISER versions). WISER is now functionally equivalent across all platforms, so there’s greater uniformity and less of a learning curve for people using different devices.
Here’s a look at what’s new in this release:
- WISER’s Help Identify Chemical capability is now available on the Android platform. Identify and validate an unknown chemical based on the following criteria:
- physical properties of the substance gathered by observation or sensors
- signs and symptoms of victims of exposure
- the ability to categorize a substance, such as a substance used in a meth lab or a flammable substance
- hazard values from NFPA 704 placards
- transportation identification, including DOT placards, type of road trailer, and type of rail car
- Use WISER’s protective distance mapping feature on your Android device. Visualize the areas likely to be affected during the first 30 minutes after a substance is spilled or released on a live map. The Department of Transportation’s Emergency Response Guidebook serves as the source of WISER’s protective distance data.
WISER for Android can be downloaded and installed directly from the Google Play Store.
Also, look for these exciting additions in the coming months:
- WISER for iOS and WISER for Android 4.5, which adds chemical reactivity, triage procedures, and WISER’s full set of radiological tools to these mobile platforms
- WISER 4.6, which will add many new substances to WISER and update much of WISER’s backend data, including its HSDB (Hazardous Substances Data Bank) substance data